newsfilter
← Latest News
PR Newswire·

Protalix BioTherapeutics Reports First Quarter 2026 Financial and Business Results

Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the discovery, development, production, and...